Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹1.2 LAccepted-AOC 127 HEMA INDUSTRIAL ESTATE SARVODAYA NAGAR MEGHWADI MUMBAI MAHARASHTRA 400060 MUMBAI MAHARASHTRA 400060 | MUMBAI SUBURBAN | MAHARASHTRA | 400060 | L1 | Accepted-AOC LOWEST BIDDER | |
| 2 | L2₹1.8 L+₹53,187.75 (42.9%)Rejected-AOC | L2 | Rejected-AOC HIGHEST BIDDER | |
| 3 | L3₹1.8 L+₹60,387.75 (48.7%)Rejected-AOC | L3 | Rejected-AOC HIGHEST BIDDER |
| Sl No | Description | Qty | Unit | Keps Pharma H3 | Nayak Pharma H2 | United Enterprise H1 |
|---|---|---|---|---|---|---|
| 1.00INJ. HUMAN ANTI D IMMUNOGLOBULIN 300 MCG | ||||||
| 1.01 | INJ. HUMAN ANTI D IMMUNOGLOBULIN 300 MCG | 45 | NOS | 2,758.05 ₹1,24,112.25 Lowest | 3,940 ₹1,77,300 | 4,100 ₹1,84,500 |
Tender Value
₹2 L
EMD Value
₹4,000
Closing Date
30 Sept 2025, 5:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
MEDICAL SUPERINTENDENT
KHAN BAHADUR BHABHA HOSPITAL KURLA WEST PIN 400070
INJ HUMAN ANTI D IMMUNOGLOBULIN 300 MCG
2025_MCGM_1221110_1
HO/KBK/5697/DATED.22.09.2025
Open Tender
Medicines
Item Rate
K B BHABHA HOSPITAL KURLA
Please refer Tender documents.
4 documents required · 4 mandatory
₹429
₹4,000
18 Feb 2026
23 Sept 2025
3 Oct 2025
23 Sept 2025
30 Sept 2025
23 Sept 2025
stage.html
html • 0.04 MB
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .